BioSpace News Archive

NeuroScience Associates (NSA Labs) and Aiforia are bringing together their respective expertise in neuroscience and artificial intelligence (AI).

Covectra, a leader in track and trace solutions, today announced AuthentiTrack Prime for Small to Medium-Sized businesses (SMB), a complete product serialization solution designed to make it easier for growing manufacturers to meet compliance needs, maximize uptime and ensure product integrity with semi-automatic or manual, low-volume packaging operation.

CAMBRIDGE, Mass. , Feb. 24, 2020 /PRNewswire/ -- TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that Raremark, a patient data platform focused on rare disease, has partnered with the TriNetX network to bring more clinical trials to its community.

SAN DIEGO , Feb. 24, 2020 /PRNewswire/ -- Neurelis, Inc., today announced that the company will be participating in the SVB Leerink 9 th Annual Global Healthcare Conference at Lotte New York Palace, New York City. Neurelis President and CEO Craig Chambliss will present at 2:15 pm EST on Tuesday , February 25. About Neurelis

Submission based on data from the Phase III PRIMA clinical study that demonstrated clinically-meaningful outcomes of niraparib maintenance treatment in the first-line setting regardless of biomarker status - The application is being reviewed under the FDA’s Real-Time Oncology Review pilot program LONDON , Feb. 24, 2020 /PRNewswire/ -- GlaxoSmithKline plc today

Innovative Forensic DNA has selected Intermountain Forensics as their lab services provider. Intermountain Forensics is the country’s first nonprofit forensic DNA lab, dedicated to bridging the gap between public and private labs.

Challenge accepted by Pro Football Hall of Fame wide receiver Jerry Rice, fans encouraged to share their best ’40-yard-dash’

Eurofins DiscoverX announces partnership with VelaLabs through their Certified CRO Program for PathHunter® Bioassays that will enable VelaLabs to perform highly reproducible potency lot release assays under GLP/GMP conditions

Feb. 24, 2020 14:00 UTC Long-term HIV Infection Can lead to Inflammatory Abnormalities Such as Cardiovascular Disease BALTIMORE--( BUSINESS WIRE )-- On February 1, the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) and OncoImmune, Inc. launched a new Phase II clinical trial called CALIBER, which will test whether OncoImmune’s lead product, CD24Fc, can reduce late effects of HIV infection, such as inflammatory abnormalities inc

Feb. 24, 2020 14:00 UTC MENLO PARK, Calif.--( BUSINESS WIRE )-- Alydia Health, a clinical-stage medical device company dedicated to making childbirth safer for all mothers, today announced the appointment of Dr. Edward Evantash as Chief Medical Officer. Dr. Evantash joins Alydia from Hologic, a global leader in women’s healthcare technology. “I’m thrilled to welcome Dr. Evantash to our outstanding and growing team at Alydia Health,” said Anne Morrissey, Chief Executive Office